» Authors » Fuzhen Zhang

Fuzhen Zhang

Explore the profile of Fuzhen Zhang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 187
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hou P, Zhu H, Chu F, Gao Y, Sun X, Zhang F, et al.
Nat Commun . 2025 Jan; 16(1):496. PMID: 39779683
Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone have been identified as tumor suppressors. However, their roles in virus infection remain unclear. Here, we demonstrate that PBLD upregulates the type I...
2.
Zhang F, Zhang Y, Yang Z, Liu R, Li S, Pang Y, et al.
J Infect Public Health . 2024 Dec; 18(2):102628. PMID: 39729671
Background: Early evaluation of culture conversion after 6-month treatment of multidrug-resistant tuberculosis (MDR-TB) is vital for outcome prediction. This study aims to merge the maximum lesion cross-sectional area observed via...
3.
Liu R, Zhang F, Li S, Liu Q, Pang Y, Li L
Metabolomics . 2024 Nov; 20(6):127. PMID: 39520502
Background: Pulmonary tuberculosis (PTB) exacerbation can lead to respiratory failure, multi-organ failure, and symptoms related to central nervous system diseases. The purpose of this study is to screen biomarkers and...
4.
Zhang F, Wang H, He H, Hou P
Vet Microbiol . 2024 Oct; 298:110290. PMID: 39471658
Signal transducers and activators of transcription 6 (STAT6), an essential member of the STAT protein family, plays vital roles in innate immunity, however, its function in regulating innate immunity through...
5.
Zhang F, Zhang F, Qin M, Li L
Microb Pathog . 2024 Oct; 196:107003. PMID: 39393473
Background: Tuberculosis (TB) is a major infectious disease in the world, and liver injury caused by anti-tuberculosis (ATTB) drugs is an important reason for reduced patient compliance with ATTB treatment....
6.
Jing W, Zhang F, Shang Y, Shi W, Yao C, Zhang X, et al.
Ann Clin Microbiol Antimicrob . 2024 Sep; 23(1):87. PMID: 39342331
Background: SQ109 is a promising candidate drug for the treatment of patients with drug-resistant tuberculosis (DR-TB). The purpose of this study was to investigate the activity of SQ109 against clinical...
7.
Zhang F, Wang Y, Zhang X, Liu K, Shang Y, Wang W, et al.
Front Med (Lausanne) . 2024 Mar; 10:1278716. PMID: 38528958
Objectives: Tuberculosis (TB) remains a significant concern in terms of public health, necessitating the timely and accurate diagnosis to impede its advancement. The utilization of oral swab analysis (OSA) presents...
8.
Zhang F, Zhang F, Li L, Pang Y
J Infect Public Health . 2024 Mar; 17(4):632-641. PMID: 38428275
Traditional methods for monitoring pulmonary tuberculosis (PTB) treatment efficacy lack sensitivity, prompting the exploration of artificial intelligence (AI) to enhance monitoring. This review investigates the application of AI in monitoring...
9.
Zhang F, Zhang F, Dong Y, Li L, Pang Y
Infect Dis Ther . 2023 Nov; 12(12):2665-2689. PMID: 37938418
Evaluating therapy efficacy is crucial for patients with tuberculosis (TB), especially those with drug-resistant tuberculosis (DR-TB). The World Health Organization currently recommends sputum smear and culture as the standard methods...
10.
Wu X, Liu K, Li S, Ren W, Wang W, Shang Y, et al.
BMC Med Genomics . 2023 Sep; 16(1):214. PMID: 37684607
Background: Dendritic cells (DCs) are most potent antigen-processing cells and play key roles in host defense against Mycobacterium tuberculosis (MTB) infection. In this study, hub genes in DCs during MTB...